Nearly one in 10 households in Great Britain now has someone taking weight-loss drugs, with roughly 2.6 million adults using the medication as of August 2026.
That share, 8.5% of homes, marks a steep climb from February, when just 6.3% of households counted a user. Uptake accelerated after once-daily weight-loss pills such as Wegovy won approval in the UK in June, giving patients an alternative to injections.
Pills now account for more than one in 10 users of these GLP-1 medications, while men are driving much of the surge. Male users have nearly doubled to 830,000 from 440,000 nine months earlier, lifting their share of all users to 32% from 23% in February.
The reach of the drugs now rivals that of everyday staples, with GLP-1 users found in almost as many homes as buyers of Kellogg's Rice Krispies or Corona beer. Household penetration is projected to top 10% in 2027.